Skip to main content
Erschienen in: Surgical Endoscopy 2/2012

01.02.2012

Transanal endoscopic microsurgery for T1 rectal cancer: size matters!

verfasst von: Pascal G. Doornebosch, Eliane Zeestraten, Eelco J. R. de Graaf, Pleun Hermsen, Imro Dawson, Rob A. E. M. Tollenaar, Hans Morreau

Erschienen in: Surgical Endoscopy | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Transanal endoscopic microsurgery (TEM) is considered a curative option for selected T1 rectal cancer. Although TEM is safe, local recurrence (LR) rates after TEM are unacceptably high. Evidence on selection criteria, however, is not abundant. To expand evidence on low- versus high-risk T1 rectal cancer with respect to LR, this study aimed to identify predictive histopathologic factors in a selected group of T1 rectal cancers treated with TEM only.

Methods

The study enrolled 62 patients for whom specimens of the primary tumor containing an invasive T1 carcinoma could be reevaluated. Tumors were scored according to predefined criteria, and analysis of predictive factors for locoregional failure was performed.

Result

Local recurrence rates at 3 years for tumors 3 cm in size or smaller were significantly lower than for tumors larger than 3 cm (16 vs. 39%; P < 0.03). Combining smaller tumors with submucosal invasion depth and budding led to identifying tumors that likely will not recur (3-year LR rates, 7 and 10%, respectively).

Conclusions

The findings showed that low- and high-risk criteria are too robust for identifying tumors at risk for LR. Tumor size alone or in combination with submucosal invasion depth or tumor budding appeared to be a significant predictive factor for locoregional failure after TEM for T1 rectal cancer.
Literatur
1.
Zurück zum Zitat Atkin WS, Cook CF, Cuzick J, Edwards R, Northover JMA, Wardle J (2002) Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 359:1291–1300PubMedCrossRef Atkin WS, Cook CF, Cuzick J, Edwards R, Northover JMA, Wardle J (2002) Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 359:1291–1300PubMedCrossRef
2.
Zurück zum Zitat You YN, Baxter NN, Stewart A, Nelson H (2007) Is the increasing rate of local excision for stage I rectal cancer in the United States justified? A nationwide cohort study from the National Cancer Database. Ann Surg 245:726–733PubMedCrossRef You YN, Baxter NN, Stewart A, Nelson H (2007) Is the increasing rate of local excision for stage I rectal cancer in the United States justified? A nationwide cohort study from the National Cancer Database. Ann Surg 245:726–733PubMedCrossRef
3.
Zurück zum Zitat Ptok H, Marusch F, Meyer F, Schubert D, Koeckerling F, Gastinger I, Lippert H (2007) Oncological outcome of local vs radical resection of low-risk pT1 rectal cancer. Arch Surg 142:649–655 (discussion 656)PubMedCrossRef Ptok H, Marusch F, Meyer F, Schubert D, Koeckerling F, Gastinger I, Lippert H (2007) Oncological outcome of local vs radical resection of low-risk pT1 rectal cancer. Arch Surg 142:649–655 (discussion 656)PubMedCrossRef
4.
Zurück zum Zitat Paty PB, Nash GM, Baron P, Zakowski M, Minsky BD, Blumberg D, Nathanson DR, Guillem JG, Enker WE, Cohen AM, Wong WD (2002) Long-term results of local excision for rectal cancer. Ann Surg 236:522–529 (discussion 529–530)PubMedCrossRef Paty PB, Nash GM, Baron P, Zakowski M, Minsky BD, Blumberg D, Nathanson DR, Guillem JG, Enker WE, Cohen AM, Wong WD (2002) Long-term results of local excision for rectal cancer. Ann Surg 236:522–529 (discussion 529–530)PubMedCrossRef
5.
Zurück zum Zitat Mellgren A, Sirivongs P, Rothenberger DA, Madoff RD, Garcia-Aguilar J (2000) Is local excision adequate therapy for early rectal cancer? Dis Colon Rectum 43:1064–1071 (discussion 1071–1064)PubMedCrossRef Mellgren A, Sirivongs P, Rothenberger DA, Madoff RD, Garcia-Aguilar J (2000) Is local excision adequate therapy for early rectal cancer? Dis Colon Rectum 43:1064–1071 (discussion 1071–1064)PubMedCrossRef
6.
Zurück zum Zitat Bentrem DJ, Okabe S, Wong WD, Guillem JG, Weiser MR, Temple LK, Ben-Porat LS, Minsky BD, Cohen AM, Paty PB (2005) T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Ann Surg 242:472–477 (discussion 477–479)PubMed Bentrem DJ, Okabe S, Wong WD, Guillem JG, Weiser MR, Temple LK, Ben-Porat LS, Minsky BD, Cohen AM, Paty PB (2005) T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Ann Surg 242:472–477 (discussion 477–479)PubMed
7.
Zurück zum Zitat Endreseth BH, Myrvold HE, Romundstad P, Hestvik UE, Bjerkeset T, Wibe A (2005) Transanal excision vs major surgery for T1 rectal cancer. Dis Colon Rectum 48:1380–1388PubMedCrossRef Endreseth BH, Myrvold HE, Romundstad P, Hestvik UE, Bjerkeset T, Wibe A (2005) Transanal excision vs major surgery for T1 rectal cancer. Dis Colon Rectum 48:1380–1388PubMedCrossRef
8.
Zurück zum Zitat Middleton PF, Sutherland LM, Maddern GJ (2005) Transanal endoscopic microsurgery: a systematic review. Dis Colon Rectum 48:270–284PubMedCrossRef Middleton PF, Sutherland LM, Maddern GJ (2005) Transanal endoscopic microsurgery: a systematic review. Dis Colon Rectum 48:270–284PubMedCrossRef
9.
Zurück zum Zitat Quirke P, Durdey P, Dixon MF, Williams NS (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 2:996–999PubMedCrossRef Quirke P, Durdey P, Dixon MF, Williams NS (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 2:996–999PubMedCrossRef
10.
Zurück zum Zitat De Graaf EJ, Doornebosch PG, Tollenaar RA, Meershoek-Klein KE, de Boer AC, Bekkering FC, van de Velde CJ (2009) Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention. Eur J Surg Oncol 35:1280–1285PubMedCrossRef De Graaf EJ, Doornebosch PG, Tollenaar RA, Meershoek-Klein KE, de Boer AC, Bekkering FC, van de Velde CJ (2009) Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention. Eur J Surg Oncol 35:1280–1285PubMedCrossRef
11.
Zurück zum Zitat Friel CM, Cromwell JW, Marra C, Madoff RD, Rothenberger DA, Garcia-Aguilar J (2002) Salvage radical surgery after failed local excision for early rectal cancer. Dis Colon Rectum 45:875–879PubMedCrossRef Friel CM, Cromwell JW, Marra C, Madoff RD, Rothenberger DA, Garcia-Aguilar J (2002) Salvage radical surgery after failed local excision for early rectal cancer. Dis Colon Rectum 45:875–879PubMedCrossRef
12.
Zurück zum Zitat Weiser MR, Landmann RG, Wong WD, Shia J, Guillem JG, Temple LK, Minsky BD, Cohen AM, Paty PB (2005) Surgical salvage of recurrent rectal cancer after transanal excision. Dis Colon Rectum 48:1169–1175PubMedCrossRef Weiser MR, Landmann RG, Wong WD, Shia J, Guillem JG, Temple LK, Minsky BD, Cohen AM, Paty PB (2005) Surgical salvage of recurrent rectal cancer after transanal excision. Dis Colon Rectum 48:1169–1175PubMedCrossRef
13.
Zurück zum Zitat Doornebosch PG, Ferenschild FT, de Wilt JH, Dawson I, Tetteroo GW, de Graaf EJ (2010) Treatment of recurrence after transanal endoscopic microsurgery (TEM) for T1 rectal cancer. Dis Colon Rectum 53:1234–1239PubMedCrossRef Doornebosch PG, Ferenschild FT, de Wilt JH, Dawson I, Tetteroo GW, de Graaf EJ (2010) Treatment of recurrence after transanal endoscopic microsurgery (TEM) for T1 rectal cancer. Dis Colon Rectum 53:1234–1239PubMedCrossRef
14.
Zurück zum Zitat Bach SP, Hill J, Monson JR, Simson JN, Lane L, Merrie A, Warren B, Mortensen NJ (2009) A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer. Br J Surg 96:280–290PubMedCrossRef Bach SP, Hill J, Monson JR, Simson JN, Lane L, Merrie A, Warren B, Mortensen NJ (2009) A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer. Br J Surg 96:280–290PubMedCrossRef
15.
Zurück zum Zitat Rothenberger DA, Garcia-Aguilar J (2000) Role of local excision in the treatment of rectal cancer. Semin Surg Oncol 19:367–375PubMedCrossRef Rothenberger DA, Garcia-Aguilar J (2000) Role of local excision in the treatment of rectal cancer. Semin Surg Oncol 19:367–375PubMedCrossRef
16.
Zurück zum Zitat Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC (2002) Tumour “budding” as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40:127–132PubMedCrossRef Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC (2002) Tumour “budding” as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40:127–132PubMedCrossRef
17.
Zurück zum Zitat Kikuchi R, Takano M, Takagi K, Fujimoto N, Nozaki R, Fujiyoshi T, Uchida Y (1995) Management of early invasive colorectal cancer: risk of recurrence and clinical guidelines. Dis Colon Rectum 38:1286–1295PubMedCrossRef Kikuchi R, Takano M, Takagi K, Fujimoto N, Nozaki R, Fujiyoshi T, Uchida Y (1995) Management of early invasive colorectal cancer: risk of recurrence and clinical guidelines. Dis Colon Rectum 38:1286–1295PubMedCrossRef
18.
Zurück zum Zitat Masaki T, Matsuoka H, Sugiyama M, Abe N, Sakamoto A, Atomi Y (2006) Actual number of tumor budding as a new tool for the individualization of treatment of T1 colorectal carcinomas. J Gastroenterol Hepatol 21:1115–1121PubMedCrossRef Masaki T, Matsuoka H, Sugiyama M, Abe N, Sakamoto A, Atomi Y (2006) Actual number of tumor budding as a new tool for the individualization of treatment of T1 colorectal carcinomas. J Gastroenterol Hepatol 21:1115–1121PubMedCrossRef
19.
Zurück zum Zitat Masaki T, Sugiyama M, Matsuoka H, Abe N, Izumisato Y, Goto A, Sakamoto A, Atomi Y (2003) Clinical utility of grading criteria for submucosal invasion in the prognosis of T1 colorectal carcinomas. J Gastroenterol 38:37–44PubMedCrossRef Masaki T, Sugiyama M, Matsuoka H, Abe N, Izumisato Y, Goto A, Sakamoto A, Atomi Y (2003) Clinical utility of grading criteria for submucosal invasion in the prognosis of T1 colorectal carcinomas. J Gastroenterol 38:37–44PubMedCrossRef
20.
Zurück zum Zitat Rasheed S, Bowley DM, Aziz O, Tekkis PP, Sadat AE, Guenther T, Boello ML, McDonald PJ, Talbot IC, Northover JM (2008) Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers. Colorectal Dis 10:231–238PubMedCrossRef Rasheed S, Bowley DM, Aziz O, Tekkis PP, Sadat AE, Guenther T, Boello ML, McDonald PJ, Talbot IC, Northover JM (2008) Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers. Colorectal Dis 10:231–238PubMedCrossRef
21.
Zurück zum Zitat Cooper HS (2007) Pathology of the endoscopically removed malignant colorectal polyp. Curr Diagn Pathol 13:423–437CrossRef Cooper HS (2007) Pathology of the endoscopically removed malignant colorectal polyp. Curr Diagn Pathol 13:423–437CrossRef
23.
Zurück zum Zitat Graham RA, Garnsey L, Jessup JM (1990) Local excision of rectal carcinoma. Am J Surg 160:306–312PubMedCrossRef Graham RA, Garnsey L, Jessup JM (1990) Local excision of rectal carcinoma. Am J Surg 160:306–312PubMedCrossRef
24.
Zurück zum Zitat Landmann RG, Wong WD, Hoepfl J, Shia J, Guillem JG, Temple LK, Paty PB, Weiser MR (2007) Limitations of early rectal cancer nodal staging may explain failure after local excision. Dis Colon Rectum 50:1520–1525PubMedCrossRef Landmann RG, Wong WD, Hoepfl J, Shia J, Guillem JG, Temple LK, Paty PB, Weiser MR (2007) Limitations of early rectal cancer nodal staging may explain failure after local excision. Dis Colon Rectum 50:1520–1525PubMedCrossRef
25.
Zurück zum Zitat Mellgren A, Goldberg J, Rothenberger DA (2005) Local excision: some reality testing. Surg Oncol Clin North Am 14:183–196CrossRef Mellgren A, Goldberg J, Rothenberger DA (2005) Local excision: some reality testing. Surg Oncol Clin North Am 14:183–196CrossRef
26.
Zurück zum Zitat Harris EI, Lewin DN, Wang HL, Lauwers GY, Srivastava A, Shyr Y, Shakhtour B, Revetta F, Washington MK (2008) Lymphovascular invasion in colorectal cancer: an interobserver variability study. Am J Surg Pathol 32:1816–1821PubMedCrossRef Harris EI, Lewin DN, Wang HL, Lauwers GY, Srivastava A, Shyr Y, Shakhtour B, Revetta F, Washington MK (2008) Lymphovascular invasion in colorectal cancer: an interobserver variability study. Am J Surg Pathol 32:1816–1821PubMedCrossRef
27.
Zurück zum Zitat Costantini M, Sciallero S, Giannini A, Gatteschi B, Rinaldi P, Lanzanova G, Bonelli L, Casetti T, Bertinelli E, Giuliani O, Castiglione G, Mantellini P, Naldoni C, Bruzzi P (2003) Interobserver agreement in the histologic diagnosis of colorectal polyps: the experience of the multicenter adenoma colorectal study (SMAC). J Clin Epidemiol 56:209–214PubMedCrossRef Costantini M, Sciallero S, Giannini A, Gatteschi B, Rinaldi P, Lanzanova G, Bonelli L, Casetti T, Bertinelli E, Giuliani O, Castiglione G, Mantellini P, Naldoni C, Bruzzi P (2003) Interobserver agreement in the histologic diagnosis of colorectal polyps: the experience of the multicenter adenoma colorectal study (SMAC). J Clin Epidemiol 56:209–214PubMedCrossRef
28.
Zurück zum Zitat Komuta K, Batts K, Jessurun J, Snover D, Garcia-Aguilar J, Rothenberger D, Madoff R (2004) Interobserver variability in the pathological assessment of malignant colorectal polyps. Br J Surg 91:1479–1484PubMedCrossRef Komuta K, Batts K, Jessurun J, Snover D, Garcia-Aguilar J, Rothenberger D, Madoff R (2004) Interobserver variability in the pathological assessment of malignant colorectal polyps. Br J Surg 91:1479–1484PubMedCrossRef
29.
Zurück zum Zitat Ono Y, Nakanishi Y, Ino Y, Niki T, Yamada T, Yoshimura K, Saikawa M, Nakajima T, Hirohashi S (1999) Clinocopathologic significance of laminin-5 gamma2 chain expression in squamous cell carcinoma of the tongue: immunohistochemical analysis of 67 lesions. Cancer 85:2315–2321PubMedCrossRef Ono Y, Nakanishi Y, Ino Y, Niki T, Yamada T, Yoshimura K, Saikawa M, Nakajima T, Hirohashi S (1999) Clinocopathologic significance of laminin-5 gamma2 chain expression in squamous cell carcinoma of the tongue: immunohistochemical analysis of 67 lesions. Cancer 85:2315–2321PubMedCrossRef
30.
Zurück zum Zitat Moriya Y, Niki T, Yamada T, Matsuno Y, Kondo H, Hirohashi S (2001) Increased expression of laminin-5 and its prognostic significance in lung adenocarcinomas of small size: an immunohistochemical analysis of 102 cases. Cancer 91:1129–1141PubMedCrossRef Moriya Y, Niki T, Yamada T, Matsuno Y, Kondo H, Hirohashi S (2001) Increased expression of laminin-5 and its prognostic significance in lung adenocarcinomas of small size: an immunohistochemical analysis of 102 cases. Cancer 91:1129–1141PubMedCrossRef
31.
Zurück zum Zitat Morodomi T, Isomoto H, Shirouzu K, Kakegawa K, Irie K, Morimatsu M (1989) An index for estimating the probability of lymph node metastasis in rectal cancers: lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer 63:539–543PubMedCrossRef Morodomi T, Isomoto H, Shirouzu K, Kakegawa K, Irie K, Morimatsu M (1989) An index for estimating the probability of lymph node metastasis in rectal cancers: lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer 63:539–543PubMedCrossRef
32.
Zurück zum Zitat Rutten HJ, den Dulk M, Lemmens V, van de Velde CJ, Marijnen CA (2008) Contreversies of total mesorectal excision for rectal cancer in elderly patients. Lancet Oncol 9:494–501PubMedCrossRef Rutten HJ, den Dulk M, Lemmens V, van de Velde CJ, Marijnen CA (2008) Contreversies of total mesorectal excision for rectal cancer in elderly patients. Lancet Oncol 9:494–501PubMedCrossRef
Metadaten
Titel
Transanal endoscopic microsurgery for T1 rectal cancer: size matters!
verfasst von
Pascal G. Doornebosch
Eliane Zeestraten
Eelco J. R. de Graaf
Pleun Hermsen
Imro Dawson
Rob A. E. M. Tollenaar
Hans Morreau
Publikationsdatum
01.02.2012
Verlag
Springer-Verlag
Erschienen in
Surgical Endoscopy / Ausgabe 2/2012
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-011-1918-4

Weitere Artikel der Ausgabe 2/2012

Surgical Endoscopy 2/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.